A Double-Blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate Biomarkers of Immunity to Varicella Zoster Virus Following Immunization With V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine or With ZOSTAVAX in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2013
At a glance
- Drugs V 212 (Primary) ; Varicella zoster virus vaccine live
- Indications Herpes zoster
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 13 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2009 Planned end date changed from 1 Feb 2010 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 27 May 2009 Actual initiation date (Nov 2009) added as reported by ClinicalTrials.gov.